RAZADYNE - 50458-388-30 - (galantamine hydrobromide)

Alphabetical Index


Drug Information of RAZADYNE

Product NDC: 50458-388
Proprietary Name: RAZADYNE
Non Proprietary Name: galantamine hydrobromide
Active Ingredient(s): 16    mg/1 & nbsp;   galantamine hydrobromide
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of RAZADYNE

Product NDC: 50458-388
Labeler Name: Janssen Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021615
Marketing Category: NDA
Start Marketing Date: 20041224

Package Information of RAZADYNE

Package NDC: 50458-388-30
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50458-388-30)

NDC Information of RAZADYNE

NDC Code 50458-388-30
Proprietary Name RAZADYNE
Package Description 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50458-388-30)
Product NDC 50458-388
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name galantamine hydrobromide
Dosage Form Name CAPSULE, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20041224
Marketing Category Name NDA
Labeler Name Janssen Pharmaceuticals, Inc.
Substance Name GALANTAMINE HYDROBROMIDE
Strength Number 16
Strength Unit mg/1
Pharmaceutical Classes Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]

Complete Information of RAZADYNE


General Information